中枢神经系统和神经系统疾病-药物靶点 SCIE

期刊简介估计审稿时候： 较慢,6-12周

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

方针和规模

《中枢神经系统和神经系统疾病 - 药物靶点》旨在涵盖神经系统和中枢神经系统 (CNS) 疾病所涉及确当代份子靶点的药归天学、药理学、份子生物学、基因组学和生归天学方面的一切最新和精采停顿，比方疾病特同性卵白质、受体、酶、基因。

《中枢神经系统和神经系统疾病 - 药物靶点》出书由该范畴带领者撰写的客座编辑专题，涵盖一系列以后中枢神经系统和神经系统药物靶点的主题。该期刊还接管颁发首创研讨文章、函件、批评和药物临床实验研讨。

跟着用于神经系统和中枢神经系统药物发明的新型人类药物靶点的发明、判定、表征和考证不时增加；这本期刊是一切到场药物发明和开辟的制药迷信家的必读读物。

《Cns & Neurological Disorders-drug Targets》(中枢神经系统和神经系统疾病-药物靶点)编辑部通信体例为BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。